Background: Lumpy skin disease (LSD), caused by lumpy skin disease virus, is an economically important transboundary cattle disease that has expanded from Africa into Asia in recent decades. Despite the substantial economic impact of LSD, sero-epidemiological evidence remains fragmented across Asia and Africa. Recurrent outbreaks and continuing geographic expansion highlight the need for pooled estimates that can guide surveillance, vaccination, and risk-based control. Objectives: Therefore, this systematic review and meta-analysis aimed to estimate the pooled seroprevalence of LSD in cattle across Asia and Africa from 2000 to 2025 and to identify study-level and animal-level factors associated with variation in seropositivity. Results: Twenty studies involving 13,356 cattle were included. The overall pooled seroprevalence of LSD was 31.2% (95% CI: 21.0-42.5), with substantial between-study heterogeneity (I² = 99.43%, p < 0.001). Pooled seroprevalence was higher in Asia (39.1%) than in Africa (22.2%) and was higher during outbreaks (44.0%) than in endemic settings (26.4%). By diagnostic method, the highest pooled estimate was observed for ELISA (36.1%), followed by virus neutralization test (33.5%) and indirect fluorescent antibody test (11.3%). Studies with smaller sample sizes showed higher pooled seroprevalence than larger studies. Meta-regression indicated that sampling year and sample size contributed significantly to heterogeneity. Risk-factor analysis showed higher odds of LSD seropositivity in cattle aged over two years (OR = 1.47; 95% CI: 1.01-2.15), females (OR = 1.32; 95% CI: 1.06-1.65), crossbred cattle (OR = 2.92; 95% CI: 1.41-6.05), and cattle managed under extensive rearing systems (OR = 1.63; 95% CI: 1.26-2.12). Conclusions: LSD seroprevalence in cattle remains substantial across Asia and Africa, although estimates vary markedly by region, study design, sample size, diagnostic method, and management factors. The findings support the need for harmonized serological surveillance, standardized reporting, risk-based vaccination, and targeted control strategies, particularly in high-risk production systems and regions with active transboundary spread.